financetom
Business
financetom
/
Business
/
Organovo's fatty liver disease drug meets main goal in mid-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Organovo's fatty liver disease drug meets main goal in mid-stage study
Apr 15, 2024 5:29 AM

April 15 (Reuters) - Organovo Holdings ( ONVO ) said on

Monday its experimental drug to treat a type of fatty liver

disease helped significantly reduce liver fat in a mid-stage

study.

(Reporting by Mariam Sunny in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved